4th GPCR-Targeted Drug Discovery Summit

Topics

• How to employ advanced technology to streamline hit-to-lead generation of small molecules and biologics?
• What is the GPCR commercial and investor opportunity?
• How to ensure selectivity and potency of GPCRs-targeted drugs?
• How to characterize the complex dynamic confirmations of GPCRs?
• How to fast-track IND-filing & accelerate the progression of novel small molecule and biologic candidates into the clinic?
• How can we comprehensively expand the repertoire of druggable GPCRs targets, including orphan GPCRs?